The Paradigm Shift from Traditional Scientific Platforms to Integrated Communications Plans
In the rapidly evolving biopharma landscape, the approach to scientific communications is undergoing a significant transformation. The shift from traditional scientific platforms to integrated communications plans (ICPs) is becoming increasingly crucial for ensuring cohesive and impactful messaging. This article delves into the components, implementation, and benefits of an ICP tailored for the biopharma industry, addressing the challenges of fragmented messaging and the need for a unified communication strategy...
Read MoreTop Stories
The Paradigm Shift from Traditional Scientific
In the rapidly evolving biopharma landscape, the approach to...
It’s Never Too Soon: How and When to
Engagement with Medical Affairs is critical at every...
Celebrating Health Literacy Month 2024:
October is Health Literacy Month, a reminder of the...
Filter
Using Digital Enhancements to Maximize Engagement: How Are Pharma and Publishers Embracing Digital?
Best practices to implement digital enhancements and measure effectiveness...
Preprints and Pharma: What Works and What Doesn’t
Pharma is cautious of preprints. But should this change? Let’s weigh the pros & cons...
3 Factors That Will Help Pharma Build Public Trust
Pharma must engage with patients at all levels to build public trust...
Future of Scientific Writing and Journal Articles with UX Design
Take a look at some ideas and examples on how user experience design can be...
How Academic Societies Are Embracing the New Digital World: A Look at the Years Gone by and Ahead
The pandemic has required traditional academic societies to rapidly pivot to digital formats for conferences...
To Preprint or Not to Preprint: Debate at the 17th Annual ISMPP Meeting
The Covid-19 pandemic has brought with it a deluge of preprints. While timely sharing of...